Market Research Logo

Zimbabwe Pharmaceuticals & Healthcare Q2 2018

Zimbabwe Pharmaceuticals & Healthcare Q2 2018

BMI View:

Zimbabwe’s small and extremely underdeveloped pharmaceutical market currently presents very few opportunities formultinational drugmakers, with many essential medicines funded by international donations. Under President Robert Mugabe, thepublic healthcare sector received only minor contributions from the government, partly a result of growing public debt. Followingthe successful replacement of Mugabe with the more reform-minded President Emmerson Mnangagwa in late 2017, we hold amore optimistic outlook. Despite the substantial headwinds facing the Zimbabwean economy, we believe the government will moveforward with reforms, facilitating an acceleration in growth and gradually improving its unattractive business environment.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: A Highly Challenging Region For Innovative Drugmakers
Regulatory Development
Regulatory Environment
Market Overview
Competitive Landscape
Company Profile
Datlabs
Varichem Laboratories
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report